Artwork

Inside Aesthetics에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Inside Aesthetics 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Dr Jake Sloane & David Segal - 'What's trending in Aesthetics? (Chapter 11 - Part 1)' #297

1:09:50
 
공유
 

Manage episode 476596187 series 2770069
Inside Aesthetics에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Inside Aesthetics 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Episode 297 showcases our hosts Dr Jake Sloane & David Segal

With political issues and the economic climate changing almost every day, we're publishing this episode out of sync with our usual Friday podcast. What we recorded just 4 weeks ago dated quite a lot and so we decided to record a second part to this episode to also address the tariff situation, the stock market volatility and what these mean for aesthetic clinics.

In Chapter 11 (Part 1) of 'What's Trending in Aesthetics,' we reflect on the introduction of another new toxin into the Australian market. We first tackle how clinics will need to understand both the clinical but also financial implications of this. We discuss the challenges of introducing new products into your business, particularly focusing on toxins and fillers.

We highlight the vital importance of:

  • Critical analysis when it comes to understanding clinical studies
  • Transparent communication with patients if you change their usual product to something else
  • Pricing strategies
  • Understanding the nuances of different toxin and filler products.

We also touch on the importance of clinical photography, scheduling routine reviews of patients, the potential pitfalls of packaging treatments and the perception of 'top-ups.'

We conclude with practical advice on balancing margins and cash flow when making business decisions when it come to purchasing and pricing products.

00:00 Introduction and Personal Updates

00:25 Workshop Insights and Business Literacy

02:19 Financial Health and Business Strategies

07:26 Engagement and Community Building

10:00 Pricing and Introducing New Products

15:39 Navigating Industry Challenges

34:16 Critical Analysis of Medical Papers

34:49 Understanding Non-Inferiority Studies

35:42 Communicating with Patients About New Products

36:39 Conducting Internal Studies and Trials

37:37 Evaluating Toxin Performance and Patient Feedback

39:18 Challenges with New Toxins

45:42 Considerations for Fillers

50:14 Pricing and Packaging Strategies

56:45 Avoiding Free Top-Ups and Setting Expectations

01:01:09 Valuing Skills Over Product Quantity

01:05:47 Final Thoughts and Practical Advice

CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH

CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS

CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US

CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST

CONTACT US

  continue reading

300 에피소드

Artwork
icon공유
 
Manage episode 476596187 series 2770069
Inside Aesthetics에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Inside Aesthetics 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Episode 297 showcases our hosts Dr Jake Sloane & David Segal

With political issues and the economic climate changing almost every day, we're publishing this episode out of sync with our usual Friday podcast. What we recorded just 4 weeks ago dated quite a lot and so we decided to record a second part to this episode to also address the tariff situation, the stock market volatility and what these mean for aesthetic clinics.

In Chapter 11 (Part 1) of 'What's Trending in Aesthetics,' we reflect on the introduction of another new toxin into the Australian market. We first tackle how clinics will need to understand both the clinical but also financial implications of this. We discuss the challenges of introducing new products into your business, particularly focusing on toxins and fillers.

We highlight the vital importance of:

  • Critical analysis when it comes to understanding clinical studies
  • Transparent communication with patients if you change their usual product to something else
  • Pricing strategies
  • Understanding the nuances of different toxin and filler products.

We also touch on the importance of clinical photography, scheduling routine reviews of patients, the potential pitfalls of packaging treatments and the perception of 'top-ups.'

We conclude with practical advice on balancing margins and cash flow when making business decisions when it come to purchasing and pricing products.

00:00 Introduction and Personal Updates

00:25 Workshop Insights and Business Literacy

02:19 Financial Health and Business Strategies

07:26 Engagement and Community Building

10:00 Pricing and Introducing New Products

15:39 Navigating Industry Challenges

34:16 Critical Analysis of Medical Papers

34:49 Understanding Non-Inferiority Studies

35:42 Communicating with Patients About New Products

36:39 Conducting Internal Studies and Trials

37:37 Evaluating Toxin Performance and Patient Feedback

39:18 Challenges with New Toxins

45:42 Considerations for Fillers

50:14 Pricing and Packaging Strategies

56:45 Avoiding Free Top-Ups and Setting Expectations

01:01:09 Valuing Skills Over Product Quantity

01:05:47 Final Thoughts and Practical Advice

CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH

CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS

CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US

CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST

CONTACT US

  continue reading

300 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드

탐색하는 동안 이 프로그램을 들어보세요.
재생